The most important Ophthalmology conference - #ARVO2024 is just days away…If you’re a researcher, a BioTech company or a research institution presenting new Gene Therapy research at #ARVO24 , I would be happy to prepare a🧵summarising your abstract. Feel free to DM & reach out

The most important Ophthalmology conference - #ARVO2024 is just days away…If you’re a researcher, a BioTech company or a research institution presenting new Gene Therapy research at #ARVO24 , I would be happy to prepare a🧵summarising your abstract. Feel free to DM & reach out

Thank you so much for this wonderful & heartwarming feedback. Many times - especially after I post a big 🧵, I think to myself if I’m not wasting my time on X & whether people are really interested in reading the things I write. Feedback like yours is what keeps me motivated. 🙏

1/Caribou Biosciences has presented in #AACR2024 preclinical data of CB-012 - its allogeneic, immune-cloaked, CAR-T Cell Therapy - engineered using $CRBU CRISPR chRDNA gene editing platform & aimed to treat Cancer patients with relapsed/refractory acute myeloid Leukaemia (r/r #AML ) $XBI

tRNA & the use of a suppressor tRNA, is IMO the next big breakthrough in treating rare Genetic diseases. Here’s a great interview with Michelle Werner - @Alltrna CEO & Flagship Pioneering’s CEO-Partner about tRNA & its therapeutic future. #SundayPodcast $XBI podcasts.apple.com/il/podcast/rai…

A great summary - made by my dear friend Jasbinder (Jessie) Chimni (My Opinions only), of the key highlights from CRISPR Therapeutics CEO - Samarth Kulkarni’s fireside chat at the Needham healthcare Conference. If you’re interested in CRISPR & BioTech please give him a Follow - if you are not doing so already… $XBI $CRSP